Fidelis Capital Partners LLC Has $422,000 Position in Agilent Technologies, Inc. (NYSE:A)

Fidelis Capital Partners LLC boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 57.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,845 shares of the medical research company’s stock after purchasing an additional 1,037 shares during the quarter. Fidelis Capital Partners LLC’s holdings in Agilent Technologies were worth $422,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of A. Wealth Enhancement Advisory Services LLC grew its holdings in Agilent Technologies by 2.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 25,107 shares of the medical research company’s stock valued at $3,653,000 after purchasing an additional 695 shares during the period. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of Agilent Technologies by 0.8% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 711,895 shares of the medical research company’s stock valued at $103,588,000 after buying an additional 5,716 shares during the period. Norden Group LLC acquired a new position in shares of Agilent Technologies in the first quarter valued at approximately $342,000. First Trust Direct Indexing L.P. boosted its holdings in shares of Agilent Technologies by 16.0% in the first quarter. First Trust Direct Indexing L.P. now owns 6,438 shares of the medical research company’s stock valued at $937,000 after buying an additional 888 shares during the period. Finally, Maryland State Retirement & Pension System boosted its holdings in shares of Agilent Technologies by 1.7% in the first quarter. Maryland State Retirement & Pension System now owns 22,932 shares of the medical research company’s stock valued at $3,064,000 after buying an additional 382 shares during the period. Institutional investors and hedge funds own 87.42% of the company’s stock.

Analyst Upgrades and Downgrades

A has been the subject of several research analyst reports. TD Cowen upped their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price target for the company. UBS Group increased their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Stifel Nicolaus restated a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a report on Monday, August 26th. Finally, Bank of America increased their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $144.36.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,995 shares of company stock worth $1,739,510. Corporate insiders own 0.33% of the company’s stock.

Agilent Technologies Trading Up 0.2 %

A stock opened at $131.51 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The company’s 50-day simple moving average is $140.01 and its 200 day simple moving average is $138.12. Agilent Technologies, Inc. has a 52 week low of $100.26 and a 52 week high of $155.35. The company has a market capitalization of $37.79 billion, a PE ratio of 27.28, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business’s revenue for the quarter was down 5.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.43 earnings per share. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were paid a $0.236 dividend. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.72%. Agilent Technologies’s payout ratio is currently 19.50%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.